Avery Dennison said today it acquired wound care device developer Finesse Medical for and undisclosed amount.
Ireland-based Finesse Medical specializes in developing wound care and skin treatment technologies, including skin barrier films and protection creams and silicone and polyurethane foam wound dressings, according to Avery Dennison.
“Finesse Medical is a top quality manufacturer with a strong track record for developing and commercializing effective, high-value products in the medical sector. This acquisition will accelerate the achievement of our long-term strategic and financial goals for our industrial and healthcare materials segment,” Avery Dennison prez & CEO Mitch Butier said in a press release.
“Finesse Medical is a great strategic fit with Vancive Medical Technologies. Its innovative portfolio of silicone gels and polyurethane foam dressings builds on and complements our existing products in wound care. And its converting and packaging capabilities will enable us to offer expanded manufacturing services to our customers,” Avery Dennison industrial & healthcare materials group GM Mike Johansen said in a prepared statement.
Finesse Medical reported revenues of approximately $16.8 million (EU €15 million) last year, according to Avery Dennison.
“Uniting our two healthcare businesses is a strategic win for both organizations and our global customer base. Our companies share a strong commitment to quality, service and innovation. Avery Dennison brings important new strengths to our business, including key relationships in the U.S. healthcare industry, new global sales and distribution channels for our products, and coating and roll manufacturing expertise that deepens our service offerings,” Finesse Medical marketing & business dev. director Martin Dowd said in a press release.